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Hydrogen sulﬁde (H2S) and nitric oxide (NO) are both gasotransmitters that can elicit
synergistic vasodilatory responses in the in the cardiovascular system, but the mecha-
nisms behind this synergy are unclear. In the current study we investigated the molecular
mechanisms through which H2S regulates endothelial NO production. Initial studies were
performed to establish the temporal and dose-dependent effects of H2S on NO generation
using EPR spin trapping techniques. H2S stimulated a twofold increase in NO production
from endothelial nitric oxide synthase (eNOS), whichwasmaximal 30min after exposure to
25–150μM H2S. Following 30min H2S exposure, eNOS phosphorylation at Ser 1177 was
signiﬁcantly increased compared to control, consistent with eNOS activation. Pharmaco-
logical inhibition of Akt, the kinase responsible for Ser 1177 phosphorylation, attenuated
the stimulatory effect of H2S on NO production. Taken together, these data demonstrate
that H2S up-regulates NO production from eNOS through an Akt-dependent mechanism.
These results implicate H2S in the regulation of NO production in endothelial cells, and
suggest that deﬁciencies in H2S signaling can directly impact processes regulated by NO.
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INTRODUCTION
Hydrogen sulﬁde (H2S) and nitric oxide (NO) are both gasotrans-
mitters (Hosoki et al., 1997; Wang, 2003) that function in the
cardiovascular system. Recent reports indicate that the NO and
H2S signaling pathways interact on a variety of levels, both in vitro
and in vivo (Geng et al., 2007; Kubo et al., 2007a,b; Yong et al.,
2008). Exogenous NaHS, a chemical source of H2S, enhances NO-
mediated relaxation up to 13-fold in isolated rat aorta (Hosoki
et al., 1997). Treatment of Langendorff-perfused Sprague-Dawley
rat hearts with NaHS immediately following ischemia confers car-
dioprotection through NOS activation (Yong et al., 2008). In a
study on the pro-angiogenic effects of NaHS in cultured endothe-
lial cells, Akt phosphorylation was induced after 30min when
the cells were exposed to 10–200μM NaHS (Cai et al., 2007).
However, this study measured NO metabolites (nitrite) instead
of NO directly, and reported that there was no increase in NO
metabolites with NaHS treatment (Cai et al., 2007). Therefore, it is
not clear whether this phosphorylation resulted in an increase in
NO bioavailability. In contrast, other in vitro studies indicate that
incubation with NaHS or H2S gas-bubbled buffer decreases eNOS
activity in aortic rings (Geng et al., 2007; Kubo et al., 2007b), cell
culture (Geng et al., 2007), and recombinant eNOS (Kubo et al.,
2007a), as well as the NO metabolites nitrite and nitrate (Geng
et al., 2007). However, in these studies NaHS incubation occurred
1–6 h before measurement of eNOS activity or NO metabolites.
Since H2S is volatile and oxidizes rapidly in the presence of oxygen
and free divalent metals (Tapley et al., 1999), key signaling events
mediated by H2S may have occurred before the activity measure-
ment was performed. There also exists direct cross-talk between
NO and H2S, and much work has been done investigating their
interaction (Whiteman and Moore, 2009). There is speculation
that an inert, nitrosothiol-like intermediate forms from the reac-
tionof the two gases,whichmay serve as a biological sink or storage
source of NO (Whiteman et al., 2006), and there is also evidence
that the interaction of the two gases may lead to formation of
nitroxyl (HNO), at least in the heart (Yong et al., 2010).
In the present study we investigated the ability of H2S, admin-
istered as the chemical source Na2S, to acutely modulate NO
bioavailability in a cultured endothelial cell system and directmea-
surement of NO,with a speciﬁc focus on the potential mechanism
of action through Akt.
MATERIALS AND METHODS
CHEMICALS
Endothelial cell growth supplement was purchased from Upstate
(Temecula, CA, USA). All other chemicals were purchased from
Sigma-Aldrich (St. Louis, MO, USA) and were of the highest
quality available, unless otherwise noted.
BAEC CULTURE
Bovine arterial endothelial cells (BAECs) were cultured in DMEM
(1.0 g L glucose) supplemented with 10% fetal bovine serum
(FBS), 1% penicillin/streptomycin, and endothelial cell growth
supplement (5mg L). Culture ﬂasks were maintained in a 37˚C
incubator at 5.0% CO2. Adherent endothelial cells were grown in
six-well plates for EPR measurements and in 100mm dishes for
protein expression measurements.
H2S EXPOSURE
Sodium sulﬁde (Na2S), an H2S donor, was made into a saturated
stock solution in distilled water and maintained at 4˚C. At this
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temperature, the concentration of a saturated solution of Na2S is
1.72M. From this stock,Na2S dilutions weremade in Krebs buffer,
of which 1.0mL was added per well of a six-well plate, and 3.0mL
was added per 100mm Petri dish. In aqueous solution, hydrogen
sulﬁde exists in equilibrium as H2S, HS−, and S2−. Therefore, the
term“H2S”used throughout this manuscript refers these chemical
species in aqueous solution from the addition of Na2S.
AKT BLOCKADE
The Akt inhibitor Triciribine was used to prevent the phospho-
rylation of eNOS (Dieterle et al., 2009). Triciribine (5.0μmol L)
was added in Krebs buffer 30min before experiments. Cells were
washed with phosphate-buffered saline (PBS) before and after
addition of Triciribine.
EPR DETECTION OF NO
Spin-trapping measurements of NO were performed using a
Bruker E-scan spectrometer (BrukerBioSpin Corporation, Biller-
ica, MA, USA) with the iron spin trapping complex N -methyl-d-
glucamine dithiocarbamate (Fe–MGD) (Cardounel and Zweier,
2002; Cardounel et al., 2007). For measurements of NO produced
byBAECs, cells were cultured as described above and spin trapping
was performedon cells grown in six-well plates (1× 106 cells well).
In these studies, cells attached to the substratumwere utilized since
scraping or enzymatic removal leads to injury and membrane
damage with impaired NO generation. The medium from each
well was removed and the cells were washed with PBS (without
CaCl2 or MgCl2). Cells in six-well plates were treated individu-
ally so that all six wells received the same treatment (i.e., addition
of Krebs buffer or Na2S in Krebs buffer) for the various exper-
iments. Next, 0.15ml of Krebs buffer containing the NO spin
trap FE–MGD (0.5mmol L Fe2+, 5.0mmol L MGD), and calcium
ionophore (A23187, 1μmol L) was added to each well and the
plates were incubated at 37˚C under a humidiﬁed environment
containing 5% CO2/95% O2 for 20min (Cardounel and Zweier,
2002; Cardounel et al., 2007). Following incubation, the medium
from two wells was removed and pooled as one 0.3ml sample,
frozen in liquid nitrogen and stored at −80˚C. This yielded three
samples per plate. The frozen NO spin-trap samples are stable,
and were later individually thawed, after which trapped NO in
the supernatants was quantiﬁed using EPR. Spectra were obtained
using the following parameters: 20mW microwave power, 3.16 G
modulation amplitude, and 100 kHz modulation frequency.
PROTEIN EXPRESSION
Six 100mm dishes were set up with two control treatments (no
Na2S addition), and the cells in four plates were exposed to
150μM Na2S. Two of these plates were sampled 15min later,
and two were sampled 30min later. To sample each plate, BAECs
from the 100mm dishes were scraped and suspended in 300μl
radioimmunoprecipitation assay (RIPA) buffer with Halt protease
inhibitor cocktail (Thermo Fisher Scientiﬁc, Rockford, IL, USA),
placed on ice, and sonicated to lyse the cells and suspend the
protein. The suspension was centrifuged at 12000× g for 20min
at 4˚C and the supernatant removed, frozen in liquid nitrogen,
and stored at −80˚C.Western blotting was performed using com-
mercially available polyclonal antibodies for eNOS and Ser 1177
eNOS (BD Biosciences, San Jose, CA, USA), monoclonal β-actin
(Cell Signaling Technology, Danvers, MA, USA), and secondary
antibody conjugated to alkaline phosphatase (Sigma-Aldrich St.
Louis, MO, USA). Protein was separated using SDS-PAGE and
transferred onto PVDF membrane (Immobilon P, Millipore, Bil-
lerica, MA, USA). Using the Snap-ID system (Millipore, Billerica,
MA, USA) membranes were blocked in 0.005% non-fat milk in
phosphate-buffered saline with 0.05% Tween-20 (PBST). Primary
antibodies were diluted 1:333 in PBST and secondary antibody
diluted 1:3,333 in blocking solution. Chemiluminescent substrate
(DuoLux, Vector Laboratories, Burlingame, CA, USA) was used
to generate a chemiluminescent signal, captured with a digital
imager (GeneSnap, Syngene, Frederick, MD, USA). Protein from
each 100mmdish of cells (N = 2 dishes per treatment) was run on
three separate blots, for a total of six independent measurements
per treatment group. Blot images were analyzed using commercial
software (Quantity One, BioRad, Hercules, CA, USA).
STATISTICS
All data were analyzed using one-way ANOVA with Dunnett’s
post hoc test for signiﬁcant differences from a control, with alpha
≤0.05 considered signiﬁcant (Prism 5.0, Graph Pad Software, La
Jolla, CA, USA).
RESULTS
Initial experiments were conducted to establish the time course of
H2S effects on endothelial NO production. BAECs were exposed
to a chemical source of H2S, Na2S (100μM) for 5, 30, 60, 90, 120
and 240min (Figure 1A). At each time point, endothelial-derived
NO production was measured using EPR. Results demonstrated
an 87% increase inmeanNOproduction at 30min post H2S treat-
ment (ANOVA, p< 0.001). This effect was not observed at later
time points, suggesting a transient activation of eNOS. Post hoc
statistical testing also revealed that levels of NO were signiﬁcantly
lower than control at the 90 and 240min time points, albeit a
small difference inmagnitude compared to the signiﬁcant increase
observed at 30min. Subsequent experiments, in which NO pro-
duction was measured 30min after the addition of 5–600μM
Na2S, were performed to establish the dose–response for the H2S
effects (Figure 1B). Results demonstrated a 39–62% increase in
meanNOproduction atNa2S concentrations between 40–150μM
(ANOVA, p< 0.001).
The transient nature of the H2S effects on endothelial NO
production suggested a change in eNOS phosphorylation status.
Therefore, western blotting was used to determine the phosphory-
lation state of eNOS after addition of H2S at 15 and 30min. Total
eNOS expression was unchanged for all treatments (Figure 2A,
ANOVA,p = 0.831), but after 30min of incubation in the presence
of 150μM Na2S, eNOS phosphorylation at Ser 1177 increased
by 100% compared to control (Figure 2B, ANOVA p< 0.001).
Furthermore, the ratio of phosphorylated Ser 1177 eNOS to
total eNOS increased by 139% after 30min compared to con-
trol (Figure 2C–D, ANOVA p = 0.0033). To determine whether
increased Ser-1177 phosphorylation was responsible for the aug-
mented NO production, BAECs were pretreated for 30min with
the Akt inhibitor Triciribine (5μM), after which the cells were
exposed to 150μM Na2S. Triciribine prevented both the increase
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FIGURE 1 |The effect of H2S on NO production by BAECs. NO
production was measured using EPR spectroscopy. NO values (y -axis)
are presented in arbitrary units and have been normalized to control.
Time (A) or Na2S treatment concentration range (B) are shown on the
x -axis. Data are shown as mean±SE. Statistical analysis was
performed using a one-way ANOVA (ANOVA p-value is in center of
ﬁgure) with Dunnett’s post hoc test. Numbers inside circles denote
the N for each column. An asterisk denotes values signiﬁcantly
different from control by post hoc test. *p<0.05, **p<0.01,
***p<0.001.
FIGURE 2 |The effect of H2S on eNOS phosphorylation. Protein
expression (y -axis, normalized to β-actin) was measured from
BAECs untreated (Ctrl), or exposed to 15 or 30min of 150μM Na2S
(x -axis). Densiometric analysis values have been normalized to control.
(A) RepresentativeWestern blots. (B)Total eNOS expression (C) eNOS
phosphorylated at Ser 1177 expression. (D)The ratio eNOS
phosphorylated at Ser 1177 expression over total eNOS expression.
Statistical analysis was performed using a one-way ANOVA (ANOVA
p-value is in center of ﬁgure) with Dunnett’s post hoc test. Numbers
inside circles denote the N for each column. An asterisk denotes values
signiﬁcantly different from control by post hoc test. **p<0.01,
***p<0.001.
in eNOS ser1177 phosphorylation as well as the augmentation
of endothelial NO production observed with H2S treatment
(Figure 3A,B, ANOVA p< 0.01). These results clearly indicate
that H2S released fromNa2S increases endothelial NO production
throughAkt activation and subsequent increased phosphorylation
of eNOS at Ser 1177.
DISCUSSION
Although an early study showed a synergistic effect of H2S on
NO-induced relaxation of blood vessel rings (Hosoki et al., 1997),
later studies showed that H2S inhibited eNOS activity in aor-
tic rings and cell culture, as well as in recombinant proteins
(Geng et al., 2007; Kubo et al., 2007a,b). However, these later
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FIGURE 3 |The effect of Akt inhibition on H2S-stimulated NO
production. (A)Western blot analysis demonstrating total, ser1177-eNOS
(phospho-eNOS), and actin in the presence and absence of the AKT
inhibitor Triciribine (5μM). (B) NO production was measured using EPR
spectroscopy. NO values (y -axis) are presented in arbitrary units and have
been normalized to control. NO was measured from untreated (Ctrl),
Triciribine treated (Ctrl+Tri.), 150μM Na2S treated (150μM H2S), and
150μM Na2S treated with Triciribine (H2S+Tri). Statistical analysis was
performed using a one-way ANOVA (ANOVA p-value is in center of ﬁgure)
with Dunnett’s post hoc test. Numbers inside circles denote the N for each
column. An asterisk denotes values signiﬁcantly different from control by
post hoc test, **p<0.01.
studies measured eNOS activity 1–6 h after H2S (NaHS) addi-
tion and did not directly measure the NO produced after addi-
tion of H2S, as we have in this study. Since H2S is volatile
and rapidly oxidizes in the presence of oxygen and free diva-
lent metals (Tapley et al., 1999), we hypothesized that H2S acts
within minutes of its application, not hours, and therefore that
an hour or longer delay between H2S application and measure-
ment of eNOS activity or, in our case, NO production could
fail to detect an effect. Here we demonstrate that H2S from
Na2S increases NO production from endothelial cells within
30min.
The comparatively rapid action of Na2S addition lead us to
suspect that H2S was stimulating phosphorylation of eNOS at
Ser 1177. We investigated by measuring total eNOS and phos-
phorylated eNOS protein expression. While total eNOS remained
constant for all treatment groups, there was a signiﬁcant increase
in both phosphorylated eNOS and the ratio of phosphorylated
eNOS to total eNOS after 30min of 150μM Na2S exposure. To
conﬁrm that H2S-induced NO production was dependent on
eNOS phosphorylation, pharmacological inhibition of Akt was
used to prevent phosphorylation of eNOS at Ser 1177. Inhibition
of Akt prevented the increase in NO production in cells exposed
to Na2S, but did not signiﬁcantly affect NO production in con-
trol cells. Nonetheless, it should be noted that Akt alone is not
the sole mechanism of phosphorylation at Ser 1177. AMPK, PKA,
and CaMKII can also contribute to phosphorylation of Ser 1177
(Fleming, 2010). Their contribution to the increase in NO by H2S
cannot be ruled out by this study, and therefore they remain targets
of further research.
While we assume that H2S gas is causing this action, hydro-
gen sulﬁde exists as H2S, HS−, and S2− in solution. With the
extracellular ratio of H2S/HS− being between 1:3 and 1:5 and the
intracellular ratio being approximately equal (Olson and Donald,
2009), HS− may also be causing the up-regulation. To our knowl-
edge, there is as yet no deﬁnitive demonstration that only H2S and
not HS− is causing the observed effects of hydrogen sulﬁde.
The concentrations of Na2S used in this study may be con-
sidered supraphysiological, given the recent ﬁnding that the cir-
culating concentration of hydrogen sulﬁde is probably in the
nanomolar range andnot in the 10 up to 300μMrange of previous
reports, many of which have used methods of measurement that
artiﬁcially inﬂated the amount of free H2S detected by the assay
by releasing bound sulfur as well as detecting free H2S (Whitﬁeld
et al., 2008; Whiteman and Moore, 2009). However, the intracel-
lular concentrations of H2S have yet to be quantiﬁed, and are
currently not known.
The data in the present study suggest a novel mechanism of
endogenous H2S signaling: up-regulation of NO production via
Akt-dependent phosphorylation of eNOS at Ser1177, although
the mechanism by which H2S activates Akt is unknown. While
it remains to be tested in vivo, upstream regulation of NO pro-
duction by H2S could represent a novel and potentially important
regulatory mechanism in NO signaling, and could further impli-
cate a dysfunction in endogenous H2S signaling in cardiovascular
disease and other pathologies.
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